February 22 Ovarian Cancer Day
Posted on Wednesday, 22 February, 2017
hundred Australian women are likely to be diagnosed with ovarian cancer this
year. The survival rate is less than half.
is these tough statistics that has seen a commitment by the Coalition
Government to improve not just awareness, but treatment outcomes and drug
Ribbon Day is an opportunity to remind ourselves of the tragedy of Ovarian and
Gynaecological Cancers - not just for the women who are affected by them, but
for their families and friends.
Coalition takes its role seriously as the biggest single funder of cancer
research in Australia. We have put up more than $107 million into ovarian
Facing ovarian cancer is a hard fight and there are so
many women fighting that fight with courage and determination. It is these
women and those who may be diagnosed in the future we must fight for.
I am pleased Health Minister Greg Hunt recently listed Olaparib on the
Pharmaceutical Benefits Scheme. Olaparib is used in the treatment of high grade
serous ovarian, fallopian, and peritoneal cancers and works by programming the
destruction of cancerous cells.
This is a drug that will help 237 women approximately in Australia this year in
their battle with ovarian cancer. What would otherwise have been more than
$100,000 a year, will now be available for $38.80 per script or $6.30 per
There is no early detection for Ovarian Cancer so sadly
as a result, women are very often diagnosed at an advanced stage, when it’s
very difficult to treat.
We are committed to raise awareness of ovarian cancer to
accelerate early diagnosis and ensure that no woman with ovarian cancer walks
Media contact: Leonie Lloyd-Smith 08
February 22 2017